State TX
Clinical Trials in Texas
Recruiting clinical trials with at least one study location in Texas. Data updated daily from ClinicalTrials.gov.
Top Conditions in Texas
NCT06348394 N/A
Recruiting
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial A...
Condition
Left Atrial Appendage Closure
Enrollment
444 pts
Location
United States
Sponsor
Baylor Research Institute
NCT04305691 Phase 2
Recruiting
Trial of Ixazomib for Kaposi Sarcoma
Condition
Kaposi Sarcoma
Enrollment
41 pts
Location
United States
Sponsor
AIDS Malignancy Consortium
NCT05408559 Phase 1, Phase 2
Recruiting
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
Condition
Diastolic Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Texas Tech University Health S
NCT06066359 Phase 1, Phase 2
Recruiting
Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-E...
Condition
Myeloma
Enrollment
44 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05489588 N/A
Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Condition
Venous Thromboses
Enrollment
165 pts
Location
United States
Sponsor
W.L.Gore & Associates
NCT05110742 Phase 1, Phase 2
Recruiting
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cel...
Condition
Hematological Malignancy
Enrollment
64 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05571059 Phase 2
Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Condition
Idiopathic Pulmonary Fibrosis
Enrollment
128 pts
Location
United States
Sponsor
Cumberland Pharmaceuticals
NCT06174727 N/A
Recruiting
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
Condition
Intracranial Aneurysm
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Montefiore Medical Center
NCT05485961 Phase 2, Phase 3
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult ...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
2,310 pts
Location
United States, Argentina, Australia
Sponsor
CSL Behring
NCT07218783 Phase 3
Recruiting
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in ...
Condition
Cataract
Enrollment
400 pts
Location
United States
Sponsor
SpyGlass Pharma, Inc.
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
NCT06336642 Phase 2, Phase 3
Recruiting
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
Condition
Dyspnea
Enrollment
150 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT06548542 Phase 2
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Moderat...
Condition
Crohn's Disease
Enrollment
540 pts
Location
United States, Austria, Belgium
Sponsor
AbbVie
NCT07218770 Phase 1, Phase 2
Recruiting
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
Condition
Active Noninfectious Uveitis Affecting the Posterior Segment
Enrollment
72 pts
Location
United States
Sponsor
Regeneron Pharmaceuticals
NCT06367959 N/A
Recruiting
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
Condition
Cancer
Enrollment
192 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07213791 Phase 1
Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Condition
Ovarian Neoplasms
Enrollment
241 pts
Location
United States, Germany, Netherlands
Sponsor
Eli Lilly and Company
NCT05518188 Phase 1, Phase 2
Recruiting
Melpida: Recombinant Adeno-associated Virus (serotype 9) Encoding a Codon Optimi...
Condition
Spasticity, Muscle
Enrollment
4 pts
Location
United States
Sponsor
Elpida Therapeutics SPC
NCT06127342 N/A
Recruiting
Exercise and Emotional Learning in Posttraumatic Stress Disorder
Condition
PTSD
Enrollment
100 pts
Location
United States
Sponsor
Christal L Badour
NCT05748873 Phase 1, Phase 2
Recruiting
Promising ROd-cone DYstrophy Gene therapY
Condition
Retinitis Pigmentosa
Enrollment
33 pts
Location
United States, France
Sponsor
SparingVision
NCT06710379 Phase 1
Recruiting
A Study of ADRX-0405 in Subjects With Select Advanced Solid Tumors
Condition
Solid Tumors
Enrollment
68 pts
Location
United States
Sponsor
Adcentrx Therapeutics
NCT05204862 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in...
Condition
Advanced Solid Tumor
Enrollment
240 pts
Location
United States, South Korea
Sponsor
TiumBio Co., Ltd.
NCT07175441 Phase 2
Recruiting
Evaluation of RBS2418 in Combination With Tremelimumab Plus Durvalumab in Partic...
Condition
Advanced Unresectable Hepatocellular Carcinoma
Enrollment
220 pts
Location
United States
Sponsor
Riboscience, LLC.
NCT06531642 Phase 2, Phase 3
Recruiting
Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute ...
Condition
Acute Kidney Injury
Enrollment
100 pts
Location
United States
Sponsor
The University of Texas Health
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT05371613 Phase 2, Phase 3
Recruiting
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Id...
Condition
Mucopolysaccharidosis II
Enrollment
63 pts
Location
United States, Argentina, Australia
Sponsor
Denali Therapeutics Inc.